Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for CLN-617, a Novel Fusion Protein Harnessing IL-2 and IL-12 Cytokines
Monday, March 27, 2023Cullinan Oncology Inc a biopharmaceutical company focused on modalityagnostic targeted oncology therapies today announced the US Food and Drug Administration FDA has cleared its Investigational New Drug IND application for CLN a fusion protein compri...
Cyclerion Therapeutics Receives U.S. FDA Orphan Drug Designation for Zagociguat for the Treatment of Mitochondrial Diseases
Monday, March 27, 2023Cyclerion Therapeutics Inc a clinicalstage biopharmaceutical company on a mission to develop treatments for serious diseases today announced that the US Food and Drug Administration FDA has granted orphan drug designation to zagociguat previously CY...
Dyne Therapeutics Receives FDA Orphan Drug and Rare Pediatric Designations for DYNE-251 for the Treatment of Duchenne Muscular Dystrophy
Thursday, March 23, 2023Dyne Therapeutics Inc a clinicalstage muscle disease company focused on advancing innovative lifetransforming therapeutics for people living with genetically driven diseases today announced that DYNE an investigational therapeutic for Duchenne muscul...
Arch Biopartners Receives Funding for Development of LSALT Peptide Drug Program
Thursday, March 23, 2023Arch Biopartners Inc a clinical stage company focused on the development of novel therapeutics targeting organ inflammation announced that Arch is receiving advisory services and up to in funding from the National Research Council of Canada Industri...
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
Wednesday, March 22, 2023Adial Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders today announced it has engaged The Keswick Group LLC a biotech strategic commercia...
Marinus Pharmaceuticals Receives FDA Orphan Drug Designation for Ganaxolone in the Treatment of Lennox-Gastaut Syndrome
Wednesday, March 22, 2023Marinus Pharmaceuticals Inc a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders today announced that the US Food and Drug Administration FDA has granted orphan drug designation ODD to ganaxolone...
WILLOW & SUANFARMA Announce Completed Development and Manufacturing Process for CBG and Commitment to the Production of New Molecules in A Natural Way
Wednesday, March 22, 2023WILLOW BIOSCIENCES and SUANFARMA today jointly announced that they have together with SUANFARMAs CIPAN manufacturing site
Techdow USA Announces FDA Approval of Generic Lovenox®, (Enoxaparin Sodium – Preservative Free) In Prefilled Syringes
Monday, March 20, 2023Techdow USA Inc Techdow USA a growing market leader and vertically integrated generic injectables company today announced the FDA approval of Enoxaparin Sodium Preservative Free in Prefilled Syringes for the US market Techdow USA is excited to bring...
SOHM, Inc. Introduces and Received Topical Skincare Line of Products Orders in Its Label
Monday, March 20, 2023SOHM Inc a generic pharmaceutical nutraceutical and cosmeceutical company that manufactures and markets generic drugs covering numerous treatment categories
Alvotech to Present Clinical Study Data for AVT04, a Proposed Biosimilar to Stelara®, at 2023 American Academy of Dermatology (AAD) Annual Meeting
Friday, March 17, 2023Alvotech a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide today announced the presentation of two posters related to its clinical studies in support of biosimilarity and clinical...
